OPTIMAL DOSAGE REGIMENS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR

被引：8

作者：

AGNELLI, G ^{[1
]}

HIRSH, J ^{[1
]}

机构：

[1] MCMASTER UNIV,DEPT MED,HAMILTON L8S 4L8,ONTARIO,CANADA

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1987年 / 13卷 / 02期

关键词：

D O I：

10.1055/s-2007-1003487

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：160 / 162

页数：3

共 29 条

[1] A COMPARISON OF THE THROMBOLYTIC AND HEMORRHAGIC EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE IN RABBITS [J].

AGNELLI, G ;

BUCHANAN, MR ;

FERNANDEZ, F ;

BONEU, B ;

VANRYN, J ;

HIRSH, J ;

COLLEN, D .

CIRCULATION, 1985, 72 (01) :178-182

[2] THE THROMBOLYTIC AND HEMORRHAGIC EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR - INFLUENCE OF DOSAGE REGIMENS IN RABBITS [J].

AGNELLI, G ;

BUCHANAN, MR ;

FERNANDEZ, F ;

HIRSH, J .

THROMBOSIS RESEARCH, 1985, 40 (06) :769-777

[3]

AGNELLI G, 1985, BLOOD, V66, P399

[4]

BERGMANN SR, 1983, SCIENCE, V220, P1181

[5] THROMBOLYTIC TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A PATIENT WITH MASSIVE PULMONARY-EMBOLISM [J].

BOUNAMEAUX, H ;

VERMYLEN, J ;

COLLEN, D .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :64-65

[6] THROMBOLYSIS WITH HUMAN EXTRINSIC (TISSUE-TYPE) PLASMINOGEN-ACTIVATOR IN RABBITS WITH EXPERIMENTAL JUGULAR VEIN-THROMBOSIS - EFFECT OF MOLECULAR-FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATION [J].

COLLEN, D ;

STASSEN, JM ;

VERSTRAETE, M .

JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (02) :368-376

[7] CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL [J].

COLLEN, D ;

TOPOL, EJ ;

TIEFENBRUNN, AJ ;

GOLD, HK ;

WEISFELDT, ML ;

SOBEL, BE ;

LEINBACH, RC ;

BRINKER, JA ;

LUDBROOK, PA ;

YASUDA, I ;

BULKLEY, BH ;

ROBISON, AK ;

HUTTER, AM ;

BELL, WR ;

SPADARO, JJ ;

KHAW, BA ;

GROSSBARD, EB .

CIRCULATION, 1984, 70 (06) :1012-1017

[8]

COLLEN D, 1984, J PHARMACOL EXP THER, V231, P146

[9]

FLEMENG W, 1985, J CLIN INVEST, V75, P84

[10] PREVENTION OF CORONARY-THROMBOSIS WITH SUBTHROMBOLYTIC DOSES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].

FOX, KAA ;

ROBISON, AK ;

KNABB, RM ;

ROSAMOND, TL ;

SOBEL, BE ;

BERGMANN, SR .

CIRCULATION, 1985, 72 (06) :1346-1354

← 1 2 3 →